Welcome to LookChem.com Sign In|Join Free

CAS

  • or

10098-39-2

Post Buying Request

10098-39-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10098-39-2 Usage

Description

4-nitrophenylglycolic acid is an organic chemical compound characterized by the molecular formula C8H7NO5. It features a nitro group, a phenyl group, and a carboxylic acid group within its structure. 4-nitrophenylglycolic acid is frequently utilized in research and chemical synthesis, serving as a valuable building block or reagent. Additionally, it plays a role in a variety of laboratory experiments and processes. Due to potential health hazards, 4-nitrophenylglycolic acid requires careful handling and management.

Uses

Used in Chemical Research and Synthesis:
4-nitrophenylglycolic acid is used as a building block and reagent in chemical research and synthesis for its versatile chemical properties and reactivity. It aids in the development of new compounds and contributes to the advancement of chemical knowledge.
Used in Laboratory Experiments and Processes:
In various laboratory settings, 4-nitrophenylglycolic acid is employed as a component in experiments and processes. Its presence can facilitate specific reactions or serve as an indicator in certain tests, making it a useful tool for scientific inquiry and analysis.
Used in Health and Safety Training:
Due to its potential health hazards, 4-nitrophenylglycolic acid is also used in training programs to educate researchers and laboratory workers on the proper handling, storage, and disposal of hazardous chemicals. This ensures a safer work environment and promotes responsible practices in chemical management.

Check Digit Verification of cas no

The CAS Registry Mumber 10098-39-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,0,9 and 8 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 10098-39:
(7*1)+(6*0)+(5*0)+(4*9)+(3*8)+(2*3)+(1*9)=82
82 % 10 = 2
So 10098-39-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H7NO5/c10-7(8(11)12)5-1-3-6(4-2-5)9(13)14/h1-4,7,10H,(H,11,12)

10098-39-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-hydroxy-2-(4-nitrophenyl)acetic acid

1.2 Other means of identification

Product number -
Other names p-nitromandelic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10098-39-2 SDS

10098-39-2Relevant articles and documents

Decomposition of sodium trichloroacetate in the presence of quaternary ammonium under microwave irradiation: A convenient one-pot synthesis of α-hydroxy acids in water

Yu, Haitao,Fang, Yun,Xia, Yongmei,Wu, Jing

, p. 2421 - 2426 (2006)

A good yielding phase-transfer-catalyzed procedure for one-pot preparation of α-hydroxy acids from carbonyl compounds and sodium trichloroacetate by in situ addition and hydrolysis under microwave irradiation is described. Decomposition of sodium trichloroacetate is strongly accelerated by the presence of quaternary ammonium. The reaction can be conducted in water. Copyright Taylor & Francis Group, LLC.

SELF-IMMOLATIVE LINKERS CONTAINING MANDELIC ACID DERIVATIVES, DRUG-LIGAND CONJUGATES FOR TARGETED THERAPIES AND USES THEREOF

-

Page/Page column 54; 94; 95, (2015/03/28)

The invention provides a therapeutic drug and targeting conjugate, pharmaceutical compositions containing these conjugates in pharmaceutical composition, and uses of these conjugates in anti-neoplastic and other therapeutic regimens. Also provided are novel intermediates thereof. The conjugates provide a therapeutic drug fragment or prodrug fragment bound to a targeting moiety via a linker which comprises a substrate cleavable by a protease such as Cathepsin B. The targeting moiety is a ligand which targets a cell surface molecule, such as a cell surface receptor on an anti-neoplastic cell. The ligand may function solely as a targeting moiety or may itself have a therapeutic effect. Following administration of the therapeutic drug and targeting conjugate of formula I and exposure of the conjugate to the protease specific for the substrate, the linker is cleaved and the targeting moiety is separated from the conjugate, which causes the drug fragment or prodrug fragment to convert to the drug or prodrug. The recited conjugates are useful in anti-neoplastic therapies. Also provided are methods of making the therapeutic drug and targeting conjugates and intermediates thereof, and kits comprising the therapeutic drug and targeting conjugates.

Ytterbium triflate-promoted tandem one-pot oxidation-cannizzaro reaction of aryl methyl ketones

Curini, Massimo,Epifano, Francesco,Genovese, Salvatore,Marcotullio, M. Carla,Rosati, Ornelio

, p. 1331 - 1333 (2007/10/03)

(Chemical Equation Presented) Ytterbium triflate was shown to be an effective catalyst in promoting the synthesis of either isopropyl esters or free α-hydroxy-arylacetic acids from substituted aromatic glyoxals and aryl methyl ketones, respectively. The reaction to provide acids starting from differently substituted ketones was carried out by an environmentally friendly method using an aqueous medium as a solvent and giving the adducts in 78-99% yield without any further purification after the usual workup.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10098-39-2